19 June 2013
Keywords: merck, kgaa, returns, rights, biomira, theratope, germany
Article | 14 June 2004
Germany's Merck KGaA and Canada's Biomira have agreed that development and commercialization rights to the therapeutic cancer vaccine Theratope
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 June 2004
© 2013 thepharmaletter.com